TheEdgeResearch
Home / Stocks / LGP.AX

Little Green Pharma Ltd (LGP.AX)

ASX Healthcare Drug Manufacturers - Specialty & Generic
$0.07 ▲ +2.74%
Market Cap
$22.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.70
52-Wk Range
0.06-0.145
CEO
Paul Frederick Long
Country
AU
Currency
AUD

Little Green Pharma Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Wembley, WA, AU. The stock last traded at $0.07, up 2.74% on the session, giving a market capitalisation of $22.9M. Its beta of 0.70 implies it has historically moved less than the broad market.

Company profile
Exchange
Australian Securities Exchange
Employees
94
IPO date
2020-02-19
Headquarters
Wembley, WA, AU
About Little Green Pharma Ltd

Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.

Comparable companies

Little Green Pharma Ltd is most often compared with the following Healthcare names:

AGH.AXAGN.AXBDX.AXEMD.AXEYE.AXIDT.AXIIQ.AXMAP.AXNXS.AXVIT.AX
More research on LGP.AX
LGP.AX technical analysis LGP.AX TheEdge Score Compare against peers
Open full interactive analysis & DCF →